Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2

Experimental Dermatology

Volumn 18, Issue 7, 2009, Pages 603-610

  Li, Min ^a   Chen, Qing ^b   Shen, Yongnian ^a   Liu, Weida ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Candida albicans; Inflammation; Keratinocytes; Phospholipomannan; Toll like receptor 2

Indexed keywords

BETA MANNOSIDASE; GLYCOLIPID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHOLIPOMANNAN; POLYMYXIN B; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CANDIDIASIS; SKIN INFLAMMATION; UPREGULATION;

CANDIDA ALBICANS; CANDIDIASIS, CUTANEOUS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLYCOLIPIDS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 66949176665     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00832.x     Document Type: Article

References (43)

1. Wisplinghoff H, Bischoff T, Tallent S M, Seifert H, Wenzel R P, Edmond M B. Nosocomial bloodstream infections in US hospitals: Analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004: 39: 309-317.
2. Wagner D K, Sohnle P G. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev 1995: 8: 317-335.
3. Schiller M, Metze D, Luger T A, Grabbe S, Gunzer M. Immune response modifiers - mode of action. Exp Dermatol 2006: 15: 331-341.
4. Wollina U, Künkel W, Bulling L et al. Candida albicans-induced inflammatory response in human keratinocytes. Mycoses 2004: 47: 193-199.
5. Mostefaoui Y, Bart C, Frenette M, Rouabhia M. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-α expression and secretion by engineered human oral mucosa cells. Cell Microbiol 2004: 6: 1085-1096.
6. Pivarcsi A, Nagy I, Koreck A et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect 2005: 7: 1117-1127.
7. Schaller M, Mailhammer R, Korting H C. Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J Med Microbiol 2002: 51: 672-676.
8. Schaller M, Mailhammer R, Grassl G, Sander C A, Hube B, Korting H C. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002: 118: 652-657.
9. Jones S A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005: 175: 3463-3468.
10. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000: 18: 217-242.
11. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007: 7: 179-190.
12. Song P I, Park Y M, Abraham T et al. Human keratinocytes express functional CD14 and Toll-like receptor 4. J Invest Dermatol 2002: 119: 424-432.
13. Kawai K, Shimura H, Minagawa M, Ito A, Tomiyama K, Ito M. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002: 30: 185-194.
14. Pivarcsi A, Bodai L, Réthi B et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003: 15: 721-730.
15. Mempel M, Voelcker V, Köllisch G et al. Toll-like receptor expression in human keratinocytes: Nuclear factor κB controlled gene activation by Staphylococcus aureus is TLR2- but not TLR4- or platelet activating factor receptor (PAFR)-dependent. J Invest Dermatol 2003: 121: 1389-1396.
16. Köllisch G, Kalali B N, Voelcker V et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005: 114: 531-541.
17. Lebre M C, van der Aar A M, van Baarsen L et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007: 127: 331-341.
18. Masuoka J. Surface glycans of Candida albicans and other pathogenic fungi: Physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 2004: 17: 281-310.
19. Netea M G, Van Der Graaf C A, Vonk A G, Verschueren I, Van Der Meer J W, Kullberg B J. The role of Toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002: 185: 1483-1489.
20. Tada H, Nemoto E, Shimauchi H et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor α by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002: 46: 503-512.
21. Jouault T, Ibata-Ombetta S, Takeuchi O et al. Candida albicans phospholipomannan is sensed through Toll-likereceptors. J Infect Dis 2003: 188: 165-172.
22. Weindl G, Naglik J R, Kaesler S et al. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 2007: 117: 3664-3672.
23. Jouault T, Bernigaud A, Lepage G, Trinel P A, Poulain D. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages. Immunology 1994: 83: 268-273.
24. T method. Methods 2001: 25: 402-408.
25. Trinel P, Jouault T, Cutler J, Poulain D. β-1, 2 mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype. Infect Immun 2002: 70: 5274-5278.
26. Poulain D, Slomianny C, Jouault T, Gomez J, Trinel P. Contribution of the phospholipomannan to surface expression of β-1, 2 oligomannosides in Candida albicans and its presence in cell wall extracts. Infect Immun 2002: 70: 4323-4328.
27. Trinel P A, Maes E, Zanetta J P et al. Candida albicans phospholipomannan, a new member of the fungal mannoseinositolphosphoceramide family. J Biol Chem 2002: 277: 37260-37271.
28. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006: 124: 783-801.
29. Poulain D, Jouault T. Candida albicans cell wall glycans, host receptors and responses: Elements for a decisive crosstalk. Curr Opin Microbiol 2004: 7: 342-349.
30. Netea M G, Gow N A, Munro C A et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006: 116: 1642-1650.
31. Jouault T, El Abed-El Behi M, Martínez-Esparza M et al. Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 2006: 177: 4679-4687.
32. Zarember K A, Godowskiv P J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002: 168: 554-561.
33. Ibata-Ombetta S, Idziorek T, Trinel P A, Poulain D, Jouault T. Candida albicans phospholipomannan promotes survival of phagocytosed yeasts through modulation of bad phosphorylation and macrophage apoptosis. J Biol Chem 2003: 278: 13086-13093.
34. Villamón E, Gozalbo D, Roig P, O'Connor J E, Fradelizi D, Gil M L. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004: 6: 1-7.
35. Villamón E, Gozalbo D, Roig P et al. Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis. Microbes Infect 2004: 6: 542-548.
36. Murciano C, Villamón E, Gozalbo D, Roig P, O'Connor J E, Gil M L. Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol 2006: 44: 149-157.
37. Netea M G, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004: 172: 3712-3718.
38. Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004: 172: 3059-3069.
39. Kang S S, Kauls L S, Gaspari A A. Toll-like receptors: Applications to dermatologic disease. J Am Acad Dermatol 2006: 54: 951-983.
40. Hatada E N, Krappmann D, Scheidereit C. NF-κB and the innate immune response. Curr Opin Immunol 2000: 12: 52-58.
41. Celec P. Nuclear factor κB - molecular biomedicine: The next generation. Biomed Pharmacother 2004: 58: 365-371.
42. Park H J, Kim H J, Kwon H J et al. UVB-induced interleukin-18 production is downregulated by tannic acids in human HaCaT keratinocytes. Exp Dermatol 2006: 15: 589-595.
43. Kjellerup R B, Kragballe K, Iversen L, Johansen C. Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. Exp Dermatol 2008: 17: 498-504.